All News

Using healthcare professionals to market products is not illegal, but has gained considerable scrutiny from authorities.

2018 U.S. drug prices, OTC/coprescribing increasing access to Naloxone, standardized opioid prescribing in children, and more.

E-cigarettes have reinvented tobacco consumption and reemphasized smoking's consequences.

Consider these services to improve your independent community pharmacy's return on investment. 

Advice from pharmacists whom have adopted new approaches in their practice.

How to build new revenue streams and show your value by expanding services.

More than 150 pharmacy stakeholder organizations - including drug chains such as Walgreens - support a Centers for Medicare and Medicaid Services’ proposal that would eliminate direct and indirect remuneration (DIR) fees.

Gerry Crocker talks with Drug Topics on his plans to grow the Association of Affiliated Pharmacies and Apothecaries (AAPArx).

Alembic Pharmaceuticals and MacLeods Pharmaceuticals have drastically increased prices as competition in valsartan and related medications was hindered by 2018 recalls.

Healthcare trails only behind retail (Walmart) as the top employment sector in America.

Using Blockchain technology, the new program will legally redispense expensive medications to those who cannot afford them.

Proposed HHS regulation would pass rebates on to consumers

Four steps that compounding pharmacists must take to restore their credibility.

What needs to be considered before independent and chain pharmacies branch into the specialty arena. 

Former Walgreens exec ‘extremely optimistic’ about the future of independent pharmacies.

How you can manage these stereotypes found in the pharmacy workplace.

Whistleblower prompts investigation into inflated prices that began in 2012.

One of our columnists recounts his major New Years moments and offers 2019 hopes for the pharmacy profession. 

A Rapid Credit program is a powerful enhancement to reverse distribution services.

Follow these pharmacists to spice up your news feed with more pharmacy-related content.

Rounding up the news you need to know to start the new year.

The dispute between the two companies highlights ongoing frustrations with the PBM model.

Approved and upcoming drugs to look forward to this year.